Revisiting ‘intensive’ blood glucose control: A causal directed acyclic graph‐guided systematic review of randomized controlled trials
Article 2022 en
Authors
CH
Chi‐Jung Huang
WW
Wei‐Ting Wang
SS
Shih‐Hsien Sung
Abstract
1 min read
The main benefits of antidiabetic agents might result from the reduction in blood sugar levels and are generally independent of drugs used. Risk reduction in MACE was proportional to the magnitude of HbA1c decrease conferred by antidiabetic agents with less hypoglycaemic hazard.
Yun-Kyoung Oh, Youn-Joo Jung, Sujata Purja, Minji Kim, Dong Keon Yon, Seung Won Lee, Kyuyeon Cho, Ai Koyanagi, Zhaoli Dai, Lee Smith, Jae Il Shin, Eun Young Kim
Discussion(0)
No comments yet. Be the first to comment.